Pin Lv
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Pin Lv has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Huifang Xu
College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China
1 shared publication - Sijia Wang
College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China
1 shared publication - Weisheng Feng
College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, P. R. China
1 shared publication - Ying Zhao
College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China
1 shared publication - Yuanyuan Li
College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China
1 shared publication - Yubo Lu
College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China
1 shared publication
Latest Publications
- Open Access
Self-Assembled Berberine-Sinapic Acid Nanomedicine for Synergistic Chemotherapy
Breast cancer ranks among the most prevalent malignant tumors globally, underscoring the urgent need for efficient and low-toxicity treatment strategies. In this study, a novel nanomedicine (BBR-SA) was constructed based on the self-assembled of berberine (BBR) and sinapic acid (SA) for synergistic chemotherapy. Firstly, utilizing π-π stacking, hydrogen bonding, and electrostatic forces between BBR and SA, the BBR-SA achieved a well-defined nanostructure with high drug-loading capacity and favorable water dispersibility. Furthermore, BBR-SA nanomedicine effectively inhibited the proliferation of mouse mammary carcinoma cells (4T1), showing a significantly stronger inhibitory effect than either BBR or SA alone. Moreover, the remarkable anti-tumor effect was obtained after treatment with BBR-SA nanomedicine in vivo, further demonstrating a synergistic therapeutic effect. More importantly, no significant systemic toxicity was observed after 28 days of intravenous administration with BBR-SA nanomedicine. In summary, the BBR-SA nanomedicine represents a safe and effective therapeutic strategy for breast cancer, offering new perspectives on the application of the traditional chinese medicine in anti-tumor therapy.
Open AccessSelf-Assembled Berberine-Sinapic Acid Nanomedicine for Synergistic Chemotherapy
Breast cancer ranks among the most prevalent malignant tumors globally, underscoring the urgent need for efficient and low-toxicity treatment strategies. In this study, a novel nanomedicine (BBR-SA) was constructed based on the self-assembled of berberine (BBR) and sinapic acid (SA) for synergistic chemotherapy. Firstly, utilizing π-π stacking, hydrogen bonding, and electrostatic forces between BBR and SA, the BBR-SA achieved a well-defined nanostructure with high drug-loading capacity and favorable water dispersibility. Furthermore, BBR-SA nanomedicine effectively inhibited the proliferation of mouse mammary carcinoma cells (4T1), showing a significantly stronger inhibitory effect than either BBR or SA alone. Moreover, the remarkable anti-tumor effect was obtained after treatment with BBR-SA nanomedicine in vivo, further demonstrating a synergistic therapeutic effect. More importantly, no significant systemic toxicity was observed after 28 days of intravenous administration with BBR-SA nanomedicine. In summary, the BBR-SA nanomedicine represents a safe and effective therapeutic strategy for breast cancer, offering new perspectives on the application of the traditional chinese medicine in anti-tumor therapy.